FDA Inspection 1274911 — Pharmaceutical Specialties, Inc.

Pharmaceutical Specialties, Inc. — FEI 2150117

The FDA completed an inspection of Pharmaceutical Specialties, Inc. on August 15, 2025 in Rochester, MN. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). 6 citations were issued during this inspection. Product area: Drugs.

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
August 15, 2025
Fiscal Year
2025
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Rochester, MN (United States)

Citations

IDCFRDescription
110521 CFR 211.22(d)Procedures not in writing, fully followed
184321 CFR 211.84(d)(2)Component written specification
188521 CFR 211.165(b)Microbiological testing
192021 CFR 211.166(a)(3)Valid stability test methods
202721 CFR 211.192Investigations of discrepancies, failures
357221 CFR 211.100(b)Procedure Deviations Recorded and Justified